Results

Total Results: 1,027 records

Showing results for "drug".

61. Screening for HIV: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/N4xvbc_aB44m95EL6TztxQ
    April 23, 2013 - Grade: A Risk Assessment Men who have sex with men and active injection drug users are at very … vaginal or anal intercourse Having sexual partners who are HIV-infected, bisexual, or injection drug … Food and Drug Administration–approved tests for detection and confirmation of HIV infection include combination

62. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication
    May 02, 2014 - What are the benefits of treatment (e.g., drug or lifestyle interventions) in adults ages 21 to 39 years … What are the harms of drug treatment for dyslipidemia in asymptomatic adults ages 21 to 39 years? … Screening for Dyslipidemia to Improve Cardiovascular Outcomes What are the benefits of drug treatment … screening strategy Other comparators not listed as included Treatment interventions Drug … and/or CVA-related morbidity or mortality; all-cause mortality KQs 2 and 3: Side effects from drug

63. Archived: Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan98/statin-use-in-adults-preventive-medication-november-2016
    May 02, 2014 - What are the benefits of treatment (e.g., drug or lifestyle interventions) in adults ages 21 to 39 years … What are the harms of drug treatment for dyslipidemia in asymptomatic adults ages 21 to 39 years? … Screening for Dyslipidemia to Improve Cardiovascular Outcomes What are the benefits of drug treatment … screening strategy Other comparators not listed as included Treatment interventions Drug … and/or CVA-related morbidity or mortality; all-cause mortality KQs 2 and 3: Side effects from drug

64. Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults: Clinical Summary of USPSTF Recommendation (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/Sttb6Qo6TFfWyR7Y8SzfH-
    June 11, 2014 - 8%), such as sub-Saharan Africa and southeast and central Asia  HIV-positive persons  Injection drug … Food and Drug Administration–approved hepatitis B surface antigen (HBsAg) test followed by a licensed … alanine aminotransferase levels; the presence of HBeAg, coinfection, and cirrhosis; and the choice of drug

65. Update on Interventions to Prevent Opioid Use Disorder | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/announcements/update-interventions-prevent-opioid-use-disorder
    May 28, 2019 -   screening for use of illicit drugs and misuse of prescription drugs  and  interventions to prevent drug

66. PII: S0749-3797(01)00255-0 (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
    January 01, 2001 - ● What are the adverse effects of diet or drug treatment? … What are the adverse effects of diet or drug treatment? … Effectiveness of Drug Therapy Effects of drug therapy on CHD events. … Summary of drug therapy effects. … Drug therapy for lipid disorders reduces the relative risk for CHD events by 30%.

67. Archived: Final Evidence Review: Hepatitis C: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review49/hepatitis-c-screening-2013
    November 15, 2012 - The virus is primarily acquired via percutaneous exposures to infected blood, such as injection drug … user, sex partners of injection drug user, received a pre-1992 blood transfusion, bacterial sexually … Two studies found screening only injection drug users would have resulted in testing of 3.0% or 5.8% … , mother is/was injection drug user, living with HCV-infected individual, living with injection drug … use (self-report) C: Injection drug use or blood transfusions (self-report) D: Injection drug

68. Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
    June 11, 2019 - Center for Drug Evaluation and Research (CDER). … US Food and Drug Administration website. … Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok … Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or … Placebo (n = 1209) PWID: Injection drug use in the previous 12 mo A vs B: Age 20-29 y: 43% vs

69. Archived: Evidence Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    June 11, 2019 - Center for Drug Evaluation and Research (CDER). … US Food and Drug Administration website. … Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok … Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or … Placebo (n = 1209) PWID: Injection drug use in the previous 12 mo A vs B: Age 20-29 y: 43% vs

70. 10th Annual Report to Congress on High-Priority Evidence Gaps (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/10th-USPSTF-Annual-Report-to-Congress.pdf
    November 01, 2020 - Unhealthy Drug Use: Screening • Evaluate screening (by asking questions about unhealthy drug use) and … interventions for unhealthy drug use in adolescents Obesity in Children and Adolescents 6. … Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. … Food and Drug Administration U.S. … unhealthy drug use in adults age 18 years or older.

71. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
    April 09, 2001 - What are the adverse effects of diet or drug treatment? … Effectiveness of Drug Therapy Effects of drug therapy on CHD events. … Effect of drug therapy on strokes. … Summary of drug therapy effects. … What are the adverse effects of diet or drug treatment?

72. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screeni
    July 05, 2005 - therapy versus no antiretroviral agents, 2-drug versus 1-drug therapy, and 3-drug versus 2-drug therapy … therapy versus no antiretroviral drugs, 2-drug versus 1-drug therapy and 3-drug versus 2-drug therapy … therapy vs. no antiretroviral agents (15 studies), 2-drug vs. 1-drug therapy (16 studies) and 3-drug … of the 9 studies of 3-drug versus 2-drug therapy. … versus placebo, 2-drug versus 1-drug therapy, and 3-drug versus 2-drug therapy.

73. Archived: Evidence Summary: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2005
    July 05, 2005 - therapy versus no antiretroviral agents, 2-drug versus 1-drug therapy, and 3-drug versus 2-drug therapy … therapy versus no antiretroviral drugs, 2-drug versus 1-drug therapy and 3-drug versus 2-drug therapy … therapy vs. no antiretroviral agents (15 studies), 2-drug vs. 1-drug therapy (16 studies) and 3-drug … of the 9 studies of 3-drug versus 2-drug therapy. … versus placebo, 2-drug versus 1-drug therapy, and 3-drug versus 2-drug therapy.

74. Clinical Summary: Screening for Hepatitis B Virus Infection in Pregnant Women (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/u7yLAN-SqsWk4TSoj-VH7V
    January 02, 2020 - Assessment In the United States, new cases of HBV among adults are largely transmitted through injection drug … with unknown HBsAg status or with new or continuing risk factors for HBV infection (eg, injection drug

75. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-may-2014
    March 15, 2013 - strategies that target persons from high prevalence countries, men who have sex with men, injection drug … behavior change counseling Antiviral treatments for treatment-naive patients (Note: Food and Drug … outcomes : virologic improvement, histologic improvement, HBeAg clearance  <3 months followup data; drug … primary care referable settings, such as correctional and community care settings serving injection drug

76. Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZrLh7o2TpPpY9WXXWbXbGk
    January 01, 2013 - The virus is primarily acquired via percutaneous expo- sures to infected blood, such as injection drug … use) C: Self-reported injection drug use (past or present) Fair Zuure et al, 2010; the Netherlands … use (self-report) C: Injection drug use or blood transfusions (self-report) D: Injection drug use … Two studies found screening only injection drug users would have resulted in testing of 3.0% or 5.8% … Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B,

77. Archived: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-virus-infection-screening-2004
    March 08, 2004 - before 1990 will continue to decline, and HCV infection will be associated mainly with intravenous drug … for HCV infection (adjusted odds ratio [OR], 23), followed by hemodialysis, sex with an intravenous drug … user, a history of blood transfusion, and male gender. 8 In cross-sectional studies of intravenous drug … Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. … Hepatitis C virus in intravenous drug users. Med J Aust 1990;153:(5):274-6. 14.

78. Ninth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
    www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/uspstf-annual-report-to-congress-2019.pdf
    January 01, 2019 - Illicit Drug Use, Including Nonmedical Use of Prescription Drug Use in Adolescents and Adults: Screening … Illicit Drug Use, Including Nonmedical Use of Prescription Drugs: Screening by Asking About Drug Use … use, frequency of drug use, or risks related to drug use. … National Institute on Drug Abuse. … National Institute on Drug Abuse.

79. Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/poDYcagnw7SqKNNbrFt_CV
    June 11, 2019 - Persons who inject drugs and have 1 of the following charac- teristics: • Shared use of drug injection … It is important that clinicians routinely take a sexual and in- jection drug use history for all their … The 2-drug antiretroviral regimen used in PrEP, when used alone, is not an effective treatment for HIV … Research is needed on different drug regimens and dosing strat- egies for PrEP. … Mathers BM, Degenhardt L, Phillips B, et al; 2007 Reference Group to the UN on HIV and Injecting Drug

80. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
    March 15, 2013 - strategies that target persons from high prevalence countries, men who have sex with men, injection drug … behavior change counseling Antiviral treatments for treatment-naive patients (Note: Food and Drug … outcomes : virologic improvement, histologic improvement, HBeAg clearance  <3 months followup data; drug … primary care referable settings, such as correctional and community care settings serving injection drug